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from 3.0% to 9.6%, depending on sex, country, 
and occupational exposure to cold, vibration, and 
stress.6-10 Capillaroscopy and laboratory tests al-
low the differentiation and exclusion of second-
ary Raynaud symptoms, most commonly found 
in connective tissue diseases.2 Moreover, nonin-
vasive measurement of capillary flow using the la-
ser Doppler flowmetry (LDF) method is helpful in 
assessing microcirculation and differentiation of 
primary and secondary Raynaud phenomenon.11 
Potential dysfunction in the microcirculation of 
the oral mucosa may promote the occurrence of 
lesions. For this reason, examination of microvas-
cular circulation is one of the best methods for 
the diagnosis of pathological changes, since there 
are no clinical parameters available that would 
INTRODUCTION Primary Raynaud phenome-
non (PRP) is the paroxysmal reversible vasocon-
strictive reaction of the small vessel arteries and 
arterioles in response to stress or low tempera-
tures, which cause limited pallor and subsequent-
ly cyanosis, as well as redness of the fingers and 
toes.1 It can also affect the lips, auricles, nose, and 
tongue.2-4 An RP attack may occur at irregular fre-
quencies and lengths, from a single annual epi-
sode to multiple times a day, lasting a few minutes 
to a couple of hours.5 Primary independent Rayn-
aud phenomenon is not accompanied by an un-
derlying disease, being the direct cause of parox-
ysmal vasospasm. Between attacks in patients 
with PRP, physical examination is usually with-
in the normal limits. The incidence of PRP varies 
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ABSTRACT
INTRODUCTION Raynaud phenomenon is a medical condition in which the spasm of the arteries causes 
episodes of reduced blood flow. Potential disorders in the microcirculation of the oral mucosa may 
promote the occurrence of lesions.
OBJECTIVES The aim of the study was to investigate the association of the frequency of oral cavity 
lesions with oral microcirculatory dysfunction in patients with primary Raynaud phenomenon (PRP) in 
comparison with healthy control group.
PATIENTS AND METHODS Measurements of oral capillary flow were performed using laser doppler 
flowmetry (LDF) in 61 patients with PRP. In a group of 31 of 61 patients (group 1), the measurements 
were made during a Raynaud phenomenon (RP) attack. The RP attack was caused by stress initiated by 
the examination or the first visit itself. The RP attack was not deliberately caused by a cold test, vibra‑
tion40w56 or any stress test. After 10 to 14 days, the measurements were repeated in all 61 patients 
and in the control group, and a dental examination was performed. Follow ‑up visits were conducted 
every 3 months for a period of 12 months to monitor oral mucosa.
RESULTS Differences in LDF were found between various anatomical points in both the PRP and con‑
trol groups. On the first visit, the LDF flow in group 1 was significantly lower at all examined points in 
comparison with those in the control group. On the second visit, differences were observed in the LDF 
of the teeth and oral mucosa temperature in all patients with PRP in comparison with controls. Oral cav‑
ity lesions reported in the past and at follow ‑up were significantly more common in patients with PRP.
CONCLUSIONS Patients with PRP have dysfunction in the microcirculation of the oral mucosa and they 
more often have lesions in the oral cavity.
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in prevention, since dysfunctions in microcir-
culation can be detected at a very early stage of 
the disease.12 In dentistry, LDF can be used to 
diagnose vascular flow changes in the connec-
tive tissue of mucosae.13-16 LDF measurements 
within the oral cavity differ depending on the an-
atomical site.13 Microcirculation of the oral mu-
cosa has not been previously studied in patients 
with PRP. In the present study, we investigated 
the association of the frequency of oral cavity le-
sions with oral microcirculatory dysfunction in 
patients with PRP in comparison with a healthy 
control group.
PATIENTS AND METHODS Patients enrolled in 
the present study were admitted for the first time 
to the microvascular disorder clinic at an angiol-
ogy center, presenting with symptoms of PRP as 
defined by the LeRoy and Medsger criteria.1 A to-
tal of 61 patients met the study criteria: 42 wom-
en and 19 men at a median age of 24 years (inter-
quartile range [IQR, 20−27], and capillary flow 
was measured using LDF on the oral mucosa, 
teeth, and lower lip vermilion (TABLE 1).1,17 At the 
same time, the temperature of the oral mucosa 
was measured. In 31 of the 61 patients (group 
1), the measurements were performed during 
an unprovoked RP attack caused by the stress of 
their first -time visit and examination. In the re-
maining 30 patients, no vasospastic attack was 
observed (group 2). The same measurements 
were performed in a control group consisting of 
50 healthy volunteers (35 women, 15 men) at a 
median age of 22.95 years (IQR, 20−26). After 
10 to 14 days, during the second visit, repeated 
measurements of capillary flow (LDF) and oral 
mucosa temperature, as well as a dental examina-
tion, were performed in all 61 patients and con-
trols. During this visit, no RP attacks were record-
ed either in group 1 or 2. A follow -up telephone 
interview was performed every 3 months for 
a period of 12 months to enquire about the pres-
ence of lesions in the oral cavity (TABLE 2). More-
over, thyroid function was assessed, rheumatoid 
factor and antinuclear antibody titers were mea-
sured, and capillaroscopic examination of nailfold 
capillaries was performed to exclude secondary 
Raynaud phenomenon.18 All inclusion and exclu-
sion criteria are presented in TABLE 3. All partici-
pants were asked to refrain from the consump-
tion of any caffeinated or alcoholic beverages pri-
or to the LDF examination.
Measurements Each examination was car-
ried out in a quiet room with increased sound 
absorption at a temperature of 21°C to 23°C. 
The oral mucosa temperature was measured us-
ing the ELLAB ctd 85 system (Copenhagen, Den-
mark) with the ELLA PRC A probe, and expressed 
in °C. The probe was positioned in the mouth’s 
vestibule at the level of the upper incisors. LDF 
measurements were performed using the Peri-
flux4001 Master apparatus (Perimed AB, Jarfal-
la, Sweden) with the Capy Flow software package 
be sufficiently reliable. Changes in microvessels 
usually occur prior to clinical manifestation and 
can be successfully used as predictors of future 
disease development, playing an important role 
TABLE 1 Demographics and basic characteristics of the examined groups
Parameter Group 1
(n = 31)
Group 2
(n = 30)
Control
(n = 50)
P value
Age, y, median 
(IQR)
24 (20−27) 23 (20−28) 22.5 (20−26) NS
Sex, female/male 22/9 20/10 35/15 NS
Thyroid function Normal Normal Normal –
RF Negative Negative Negative –
ANA Negative Negative Negative –
Smoker No No No –
Mean PRP 
duration, mo
48 (8) 51 (7) – NS
Mean RP attack 
frequency, per 
mo
2 (1.5) 3 (1.2) – NS
Vasoactive drugs No No No –
Abbreviations: ANA, antinuclear antibodies; IQR, interquartile range; NS, nonsignificant; 
PRP, primary Raynaud phenomenon; RF, rheumatoid factor; RP, Raynaud phenomenon
TABLE 2 Study timeline
Visit 1 (enrollment) Visit 2 (check ‑up) 10–14  
days later
Follow ‑up
Capillary flow 
measurement LDF, 
oral mucosa 
temperature
Capillary flow measurement 
LDF, oral mucosa 
temperature, dental 
examination
Telephone call every 
3 months for 12 months: 
an interview about 
the presence of trophic 
lesions
Abbreviations: LDF, laser Doppler flowmetry
TABLE 3 Study inclusion and exclusion criteria
Inclusion criteria
Symptoms of PRP as defined by LeRoy and Medsger criteria
Aged 18 to 35 years old
Informed consent for participation in the study
Exclusion criteria
Autoimmune diseases
Thyroid disorders
Diabetes mellitus
Immunosuppressive treatment within the previous 6 months
Dental defects potentially harming oral cavity mucosa during dental exam
Bleaching within the previous 3 months17
Use of orthodontic appliances within the previous 6 months
Movable denture use
Declaration of failure to brush teeth at least twice a day
Current smoking
Hypertension and the use of antihypertensive drugs; use of vasoactive or other 
medications that could influence blood circulation
Pronounced gag reflex
Nailfold capillary morphological abnormalities on capillaroscopy
Abbreviations: see TABLE 1
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from the study. No specific indices were used for 
the evaluation of dental health.
Questionnaire Each participant was given 
a questionnaire with the following questions 
enquiring about the frequency of RP attacks and 
the occurrence and type of lesions in the oral 
cavity in the past and their annual frequen-
cy: 1) the frequency of RP attacks: everyday; 
>1 × a week but not on the daily basis, 1 × in few 
weeks, occasionally; 2) the type of oral cavity 
lesions: erosion (small 2–5 mm, large >10 mm, 
the size of pinhead, confluence); vesicle; angle 
of the mouth redness or crack; other; 3) the fre-
quency of occurrence of oral cavity lesions: re-
occuring within a short period of time – seem 
to persist continuously; every 1 to 4 months; 
less frequent.
Ethics The study protocol was approved by Ja-
giellonian University Medical College Bioeth-
ics Committee. Written informed consent was 
provided by each participant prior to inclusion 
in the study. The present study was conducted 
in accordance with the 1963 Declaration of Hel-
sinki and its later amendments.
Statistical analysis Gaussian distribution esti-
mation of variables was performed using the Kol-
mogorov–Smirnov and Shapiro–Wilk normality 
tests. For descriptive analysis, quantitative vari-
ables are represented as the median and IQR, 
since they exhibited non–Gaussian distribu-
tions. Categorical variables are represented as 
a simple frequency and percentage. Categorical 
variables were estimated using the Fisher exact 
test. For comparison of the medians of indepen-
dent variables with nonparametric distribution, 
the Mann–Whitney test was used, and for medi-
ans of dependent variables with nonparametric 
distribution, the same was applied. Correlations 
were tested using the Spearman rank test. For 
comparison of the medians of numeric variables 
with more than 2 categorized groups, the Krus-
kal–Wallis analysis of variance was used followed 
by the post -hoc Dunn’s multiple comparison test 
to assess measurements between groups, and 
the Dunnett’s test for comparison with the con-
trol when the general tests were significant.
RESULTS All results of LDF and tempera-
ture measurements in group 1 at visit 1 were 
significantly lower in comparison with those 
at visit 2 when a paroxysmal capillary spasm 
was not present and LDF flow and tempera-
ture normalization occurred (TABLE 4). At visits 
1 and 2, we compared the medians of LDF mea-
sured on the palate, gingiva, lip, buccal muco-
sa, and teeth, as well as the oral mucosa tem-
perature in groups 1 and 2 versus healthy con-
trols. During the first visit, all the above mea-
surements were significantly lower in group 1 as 
compared with the control (palate, 6.9 [IQR, 
6.10−8.10] vs 30.80 [IQR, 25.90−38.40); gingiva, 
for registration and analysis of results. The ap-
paratus was equipped with a probe of standard 
fiber separation (0.25 mm) and a 780 -nm wave-
length laser with a measuring depth of 0.5 to 
1.2 mm. The probe was stabilized by acrylic mass 
on the: 1) teeth − 1/3 gingival crown of the max-
illary anterior incisors; 2) palatal mucosa (Schro-
eder area), as previously described;19 3) gingiva 
over the maxillary anterior incisor; 4) lower lip 
vermilion;20,21 and 5) internal buccal surface.
The baseline microvascular blood flow was sub-
sequently measured for a duration of 1 minute. 
LDF measurements were expressed in arbitrary 
perfusion units (periflux unit [PU]). The degree of 
adhesion of the probe to the oral mucosa, teeth, 
and vermilion was controlled by the flowmeter 
sensor. Previously untreated teeth, and oral mu-
cosae and lips without macroscopic changes were 
chosen for LDF measurement, which was per-
formed by 2 angiologists with many years of ex-
perience. The intra- and interobserver reliability 
was calculated using the reliability statistics of 
intraclass correlation. The reliability was excel-
lent for all measured parameters. No measure-
ments were rejected for technical reasons. There 
were no systematic differences between the first 
and second measurement or between observers.
Dental examination During the second visit, den-
tal examinations were performed by a certified 
dentist, which included the inspection and pal-
pation of the oral cavity vestibule mucosa, main 
oral cavity, gingiva, lip angles, and lips. The type 
and topography of lesions were described and 
noted. Aphte were rated according to the classi-
fication into minor, major, and herpetiform le-
sions. In addition, the state of dentition was as-
sessed to check for potential abnormalities that 
would exclude the patient from further participa-
tion in the study. Dentition state was evaluated 
using a dental probe and dental mirror following 
the procedures of a standard physical examina-
tion. Based on that exam, all patients with active 
dental caries, incorrect tooth fillings, or fillings 
that irritate mucose membrane were excluded 
TABLE 4 Median laser Doppler flowmetry (periflux unit [PU]) and oral mucosa 
temperature (M_tmp) on visits 1 and 2 in group 1 (n = 31)
Visit 1 Visit 2 P valuea
Palate 6.9 (6.1–8.1) 29.3 (26.9−34.7) <0.001
Gingiva 10.7 (9.1−12.2) 37.1 (31.1−40.1) <0.001
Buccal 
mucosa
8.1 (6.5−10.9) 33.7 (28.9−39.9) <0.001
Lip 9.6 (7.7−11.8) 33.8 (27.2−36.8) <0.001
Tooth 1 14.4 (12.8−16.6) 15.5 (13.8–18.1) 0.004
Tooth 2 11.9 (10.9−13.3) 12.9 (11.1−16.1) 0.07
M_tmp 34.1 (33.5−34.5) 36.2 (36−36.7) <0.001
a Visit 1 vs visit 2
Data were compared using the Wilcoxon test.
Abbreviations: M_tmp, oral mucosa temperature
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mentioned previously19 (Supplementary mate-
rial, Figure S1). During the dental examination 
at visit 2, 24 patients with PRP and 12 individ-
uals from the control group had superficial le-
sions in the oral mucosa: minor aphtha, herpes 
labialis, and angular cheilitis. Oral cavity lesions 
confirmed at the dental visit were significantly 
more common in patients with PRP as compared 
with control individuals (TABLE 6). We found no 
direct correlation between the frequency of le-
sions and the frequency of vasospastic parox-
ysms reported by patients; however, lesions found 
at the dental visit were more common in group 
1 as compared with group 2 (16 of 31 [51.6%] 
and 8 of 30 [26.66%]; P = 0.04) and the control 
group (12 of 50 [24%]; P = 0.01). Interestingly, 
oral cavity lesions reported by patients in the past 
as well as at follow -up visits were significantly 
more common in both RP groups in comparison 
10.7 [9.1−12.2] vs 38.60 [26.20−42.80]; buccal 
mucosa, 8.1 [6.5−10.9] vs 37.75 [29.8−40.2]; lip, 
9.60 [7.7−11.8] vs 28.50 [21.90−34.80]; teeth 
1, 14.4 [12.8−16.6] vs 21.9 [18.9−26.2]; teeth 2, 
11.9 [10.9−13.3] vs 23.3 [17.9−29.8]) (TABLE 5, 
FIGURE 1). At these visits, LDF values were also sig-
nificantly lower in group 1 than in group 2 (Sup-
plementary material, Table S1) In group 2, at the 
first visit, no significant differences were observed 
in comparison with controls (TABLE 5); however, 
at the second visit, significant differences were 
seen in the LDF of the teeth and mucosa temper-
ature in both PRP groups in comparison with con-
trols (TABLE 5, FIGURE 2). At visit 2, when no RP at-
tack was observed, we compared the LDF among 
different anatomical points in both RP groups 
and the healthy control group. Significant dif-
ferences were found, with the lowest values be-
ing observed on the teeth, which has not been 
TABLE 5 Median capillary laser Doppler flowmetry, periflux unit, and oral mucosa temperature at visit 1 and 2
Group 1
(n = 31)
Group 2
(n = 30)
Control
(n = 50)
P value
Visit 1
Palate 6.9 (6.1–8.1)a 29.00 (26.90−33.30)b 30.80 (25.90−38.40) <0.001a
NSb
Gingiva 10.7 (9.1−12.2)a 35.55 (27.90−39.70)b 38.60 (26.20−42.80) <0.001a
NSb
Buccal mucosa 8.1 (6.5−10.9)a 39.8 (31.2−43.8)b 37.75 (29.8−40.2) <0.001a
NSb
Lip 9.6 (7.7−11.8)a 30.40 (27.20−32.90)b 28.50 (21.90−34.80) <0.001a
NSb
Tooth 1 14.4 (12.8−16.6)a 15.15 (10.9−19.6)b 21.9 (18.9−26.2) <0.001a
NSb
Tooth 2 11.9 (10.9−13.3)a 14.8 (11.7−20.6)b 22.3 (17.9−29.8) <0.001a
NSb
M_tmp 34.1 (33.5−34.5)a 36.55 (36.20−36.80)b 36.75(36.50−36.90) <0.001a
NSb
Visit 2
Palate 29.3 (26.90−34.70) 31.00 (28.60−32.80)   30.55 (26.80−36.10) 0.7a
0.6b
Gingiva 37.1 (31.10−39.90) 34.80 (29.90−40.80)   39.40 (32.20−45.50) 0.3a
0.09b
Buccal mucosa 33.7 (29.6−40.6) 37.85 (29.3−50.4)   39.25 (33.9−43.2) 0.08a
0.1b
Lip 33.80 (27.2−36.80) 32.35 (27.90−37.10)   36.20 (28.40−38.70) 0.4a
0.3b
Tooth 1 15.5 (13.8–18.1)a 15.85 (13.3−18.9)b   25.8 (19.6−30.8) <0.001a
<0.001b
Tooth 2 12.9 (11.1−16.1)a 15.5 (12.8−20.1)b   22.3 (19.9−33.8) <0.001a
<0.001b
M_tmp 36.40 (36.00−36.70)a 36.60 (36.40−36.70)b   36.70 (36.60−36.90)a,b <0.001a
<0.001b
Data were compared using the Kruskal−Wallis analysis of variance and post ‑hoc Dunnett’s test.
a Group 1 vs control
b Group 2 vs control
Abbreviations: see TABLE 4
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DISCUSSION Measurement of the microcircula-
tion in the oral cavity has been described as a use-
ful method for the detection of microvessel dys-
function and the diagnosis of palatal mucosal pa-
thologies.10,16 Here, we focused on microvascular 
with the control group (TABLE 6; Supplementary 
material, Figure S2). No significant correlations 
between RP attack frequency reported by patients 
in the questionnaire and LDF flow or mucosa tem-
perature were shown.
FIGURE 1 Enrollment 
visit (visit 1); laser 
Doppler flowmetry and 
oral mucosa temperature 
(m_tmp) in groups 1, 2, 
and controls
a Significant 
differences
FIGURE 2 Control visit 
(visit 2); laser Doppler 
flowmetry and oral 
mucosa temperature 
(m_tmp) in groups 1, 2, 
and controls  
a Significant 
differences: group 1 vs 
control  
b Significant 
differences: group 2 vs 
control
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temperatures and emotional stress.3,38 α -2 adren-
ergic receptors are present on the distal arterial 
smooth muscles and are affected by the sympa-
thetic nervous system, causing a perfusion dis-
order, which may induce other disease process-
es.2,39 In this case, paroxysmal ischemia of the 
oral cavity mucosae and vermillion border might 
be the predisposing factor to other pathomecha-
nisms in the etiology of oral cavity lesions.
Conclusions Patients with PRP present the dis-
orders of the oral cavity’s mucosa microcircula-
tion, and oral cavity lesions are more common in 
this group of patients.
SUPPLEMENTARY MATERIAL Supplementary ma-
terial is available with the article at www.pamw.pl.
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